Concepedia

Author

Barbara Grohmann-Izay

Medical University of Vienna

Also Known As

B. Grohmann-Izay, B. Grohmann‐Izay, Barbara Grohmann-Izay

13

Publications

504

Citations

8

H-Index

8

Concepts

All Affiliations

Medical University of ViennaAOP Orphan (Austria)Austrian Academy of SciencesInsermHôpital Saint-Louis
BG

About

Barbara Grohmann-Izay is an author at Medical University of Vienna specializing in medicine, maternal health, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

341

2

Health Sciences

1

1

327

3

Obstetrics

1

1

14

4

Clinical Trials

1

1

327

5

Hematology

1

1

327

Barbara Grohmann-Izay

×

8

Publications

487

Citations

8

H-Index

YearCitations

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev,

The Lancet Haematology

2020

327

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

Emmanuelle Verger, Juliette Soret‐Dulphy, Nabih Maslah,

Blood Cancer Journal

2018

51

Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients

Heinz Gisslinger, Christoph Klade, Pencho Georgiev,

Blood

2016

28

Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial

Martin Unger, Andrea Morelli, Mervyn Singer,

Trials

2018

21

Evidence for Superior Efficacy and Disease Modification after Three Years of Prospective Randomized Controlled Treatment of Polycythemia Vera Patients with Ropeginterferon Alfa-2b Vs. HU/BAT

Heinz Gisslinger, Christoph Klade, Pencho Georgiev,

Blood

2018

19

Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera — Final Phase I/II Peginvera Study Results

Heinz Gisslinger, Veronika Buxhofer‐Ausch, Josef Thaler,

Blood

2018

16

Correlation of the volume of ectopic pregnancy and MTX therapy outcome: a retrospective cohort study

S. Helmy, Marianne Koch, H. Kölbl,

European Journal of Obstetrics & Gynecology and Reproductive Biology

2014

14

Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults

Gerald Aichinger, Barbara Grohmann-Izay, Maikel V. W. van der Velden,

Clinical and Vaccine Immunology

2014

11

Page 1